Allopurinol Tablet
Product Images NDC 51655-082

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 51655-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-082-52 (51655 082 52 Rev A 03 23)

This is a description for Allopurinol 100mg Tablets, USP that contains a National Drug Code (NDC): 516§5-082-52. The medication is intended for prescription use only and is sold in a container that holds 30 tablets. The recommended storage temperature range for the tablets is between 20°C - 25°C. Sun Pharmaceutical Industries, Inc., Lot Indianapolis, IN 46203 has repackaged the medicine for Northwind Pharmaceuticals. It is crucial to keep the medicine away from children and store it in the original container. There is additional information regarding the dosage and packaging included within this description.*

FDA Label Image

Structure (Allopurinol 01)

FDA Label Image

Figure (Allopurinol 02)

Allopurinol and oxipurinol are compounds that are used to treat gout and hyperuricemia. Allopurinol is a derivative of hypoxanthine while oxipurinol is formed from allopurinol. They work by inhibiting xanthine oxidase, which is responsible for the conversion of hypoxanthine to xanthine and ultimately to uric acid. They can also inhibit the formation of purine nucleotides.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.